FDA approves microdesigned bone implants

May 30, 2003 – Therics Inc. has received approval from the U.S. Food and Drug Administration to sell its microfabricated bone graft substitute, according to a company release.

Therics, a subsidiary of Tredegar Corp., said its biocompatible bone replacement, called TheriRidge, is intended to augment deficient mouth and jaw bones. The microfabricated process, known as TheriForm, offers precise shaping and placement of many materials into complex three-dimensional implants, the release said.

Therics, a Princeton, N.J.-based developer of 3-D printing technology for life science applications, licensed the TheriForm technology from Massachusetts Institute of Technology.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.